Dexmedetomidine

Current Opinion in Critical Care

Volumn 7, Issue 4, 2001, Pages 221-226

  Coursin, Douglas B ^a,e   Coursin, Drew B ^b   Maccioli, Gerald A ^c,d  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b MACALESTER COLLEGE   (United States)

^c Critical Health Systems Inc   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e B6/319 UW CSC ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; BENZODIAZEPINE DERIVATIVE; CLONIDINE; DEXMEDETOMIDINE; NARCOTIC AGENT; PROPOFOL;

ADRENERGIC ACTIVITY; ANALGESIA; BRADYCARDIA; CLINICAL TRIAL; DRUG APPROVAL; DRUG EFFICACY; DRUG INFUSION; DRUG RECEPTOR BINDING; DRUG SAFETY; HUMAN; HYPERTENSION; HYPOTENSION; INTENSIVE CARE UNIT; LOCUS CERULEUS; META ANALYSIS; PATIENT SELECTION; REVIEW; SEDATION;

DEXMEDETOMIDINE; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS;

EID: 0034834555     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-200108000-00002     Document Type: Review

References (43)

1. Revised clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult
2. Crit Care Med
3. Balancing sedation and analgesia in the critically ill
4. Sedation in the intensive care unit: A systematic review
5. Patterns of prescribing and administering drugs for agitation and pain in patients in a surgical intensive care unit
6. Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure
7. A national survey on the practice patterns of anesthesiologist intensivists in the use of muscle relaxants
8. Complications associated with sedative and neuromuscular blocking drugs in critically ill patients
9. The use of continuous IV sedation is associated with prolongation of mechanical ventilation
10. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation
11. Optimal intravenous dosing strategies for sedatives and analgesics in the intensive care unit
12. Pharmacokinetics of dopamine in healthy male subjects
13. Clinical predictors and outcomes for patients requiring tracheostomy in the intensive care unit
14. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation
15. Physician responses to an educational intervention on improving their long-term prescribing of sedatives
16. Introduction of sedative, analgesic, and neuromuscular blocking agent guidelines in a medical intensive care unit: Physician and nurse adherence
17. Alpha-2 and imidazoline receptor agonists: Their pharmacology and therapeutic role
18. 2-adrenergic agonists
19. Alpha-2 adrenoreceptors in pain modulation: Which subtype should be targeted to produce analgesia?
20. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha-2-adrenoceptor antagonist atipamezole: A pharmacodynamic and kinetic study in healthy volunteers
21. Receptor-specific reversible sedation: Beginning of new era of anesthesia?
22. Pharmacology of spinal adrenergic systems which modulate spinal nocioceptive processing
23. Preliminary UK experience of exmedetomidine, a novel agent for postoperative sedation in the intensive care unit
24. Alpha-2-adrenergic agonists for regional anesthesia: A clinical review of clonidine (1984-1995)
25. Dexmedetomidine
26. Dexmedetomidine - A novel sedative for postoperative sedation
27. Effects of intravenous dexmedetomidine in humans: Part II: Hemodynamic changes
28. Effects of intravenous dexmedetomidine in humans: Part I: Sedation, ventilation, and metabolic rate
29. Sedative, amnestic, and analgesic properties of dexmedetomidine
30. The effect of clonidine and dexmedetomidine on human neutrophil functions
31. The effects of increasing plasma concentrations of dexmedetomidine in humans
32. Effect of dexmedetomidine on propofol requirements in healthy subjects
33. The effects of dexmedetomidine on neuromuscular blockade in human volunteers
34. A phase III study evaluating dexmedetomidine for sedation in postoperative patients
35. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting
36. Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery
37. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery
38. The use of dexmedetomidine infusion for awake craniotomy
39. Dexmedetomidine and hemodynamic responses to simulated hemorrhage in experimental heart failure
40. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care
41. Ventilatory, hemodynamic and sedative effects of the alpha 2 adrenergic agonist, dexmedetomidine
42. Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia
43. Immunomodulation by anesthetic, sedative and analgesic agents: Does it matter?